OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Chapman on Vemurafenib Combination Therapies

June 16th 2011

Dr. Chapman from Memorial Sloan-Kettering Cancer Center on Vemurafenib Combination Therapies

Dr. Hoos Discusses Key Points of the Ipilimumab Trial

June 15th 2011

Dr. Hoos From Bristol-Myers Squibb Discusses Key Points of the Ipilimumab Trial

Dr. Chapman Describes Recent Melanoma Advances

June 15th 2011

Dr. Chapman From Memorial Sloan-Kettering Cancer Center Describes Recent Melanoma Advances

Dr. Virgo Shares the Results of the PCP/MO Barriers Study

June 14th 2011

Dr. Virgo From American Cancer Society Shares the Results of the PCP/MO Barriers Study

Dr. Kris Discusses Methotrexate in ALL

June 14th 2011

Dr Kris From Memorial Sloan-Kettering Cancer Center Discusses Methotrexate in Acute Lymphocytic Leukemia

Dr. Paz-Ares Discusses Pemetrexed Clinical Trial

June 13th 2011

Dr Paz-Ares from Seville University Hospital Discusses Pemetrexed Clinical Trial

Dr. Chapman Describes the Vemurafenib Clinical Trial

June 10th 2011

Dr. Chapman From Memorial Sloan-Kettering Describes the Vemurafenib Clinical Trial

Dr. Vogelzang Discusses Cabozantinib Trial Design

June 9th 2011

Dr. Vogelzang from the Comprehensive Cancer Centers of Nevada Discusses Cabozantinib Trial Design

Dr. Infante on the Future of BRAF Inhibitors in Melanoma

June 8th 2011

Dr. Infante from Sarah Cannon Research Institute on the Future of BRAF Inhibitors in Melanoma

Dr. Joensuu Discusses the Progress of GIST Treatments

June 8th 2011

Dr. Heikki Joensuu from the Helsinki University Central Hospital Discusses the Progress of gastrointestinal stromal tumors (GIST) Treatments

Ruth Rechis on the Needs of Cancer Survivors

June 3rd 2011

Ruth Rechis from LIVESTRONG on the Key Points of Her Presentation

Dana Monroe Discusses Ipilimumab's Side Effects

June 2nd 2011

Dana Monroe from San Francisco Oncology Associates Discusses Ipilimumab's Side Effects

Carlton Brown Describes the ONS Social Media Efforts

June 2nd 2011

Oncology Nursing Society President Carlton Brown Describes the ONS Social Media Efforts

Karen Hagemaster on Chemo Documentation Study Results

June 1st 2011

Karen Hagemaster From Advocate Good Samaritan Hospital on Chemotherapy Documentation Study Results

ONS President Carlton Brown's War on Cancer Perspective

June 1st 2011

Carlton Brown President of the Oncology Nursing Society (ONS) Gives His Perspective on the War on Cancer

Colleen O'Leary Describes Chemotherapy Safety

May 31st 2011

Colleen OLeary from James Cancer Hospital Describes Chemotherapy Safety Standards

Reynaldo Garcia Explains the BCR-ABL Study

May 31st 2011

Reynaldo Garcia from the UNC Lineberger Comprehensive Cancer Center Explains the BCR-ABL Study

Reynaldo Garcia on BCR-ABL Testing in CML

May 27th 2011

Reynaldo Garcia from the University of North Carolina Lineberger Comprehensive Cancer Center on BCR-ABL Testing in Chronic Myelogenous Leukemia

Donna Berry on the Future of Oncology Nursing

May 26th 2011

Donna Berry from the Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Future of Oncology Nursing

Donna Berry on the Implications of Oral Oncolytics

May 26th 2011

Donna Berry from the Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Implications of Oral Oncolytics